KP

R New York Senate · District 1 · Former member

Sen. Kenneth P. LaValle

Contact Email

Compare

Total votes

8,929

all sessions

Attendance

94%

320 missed

Lower than 96% of chamber peers

With party

95%

of cast votes

Lower than 93% of chamber peers

Bipartisan score

2%

crosses aisle rarely

Higher than 90% of chamber peers

Voting record

Yea

7,880

voted in favor

Nay

581

voted against

Absent

320

missed votes

Total cast

8,929

across all sessions

Crossed party

405

votes against own party

This page

8,929

matching current filters

Bill

Description

Vote

Result

Tally

Date

S 658

Relates to classifying U-47700 (Pink) as a schedule I opiate

Yea

Passed

58–1

Apr 24, 2017

S 4492

Relates to a report on the impact of a tax deduction for expenses of the adoption of a special needs child

Yea

Passed

7–0

Apr 24, 2017

S 300

Designates Xylazine as a schedule III depressant controlled substance

Yea

Passed

58–1

Apr 24, 2017

S 2639

Requires hospital and emergency room physicians to notify a patient's prescriber that such patient is being treated for a controlled substance overdose

Yea

Passed

59–0

Apr 24, 2017

S 2248

Directs hospitals, office-based surgery practices and health care providers who accept walk-in patients, who are not regularly seen by the provider, to utilize and maintain an electronic health records system

Yea

Passed

54–5

Apr 24, 2017

S 542

Relates to the report of programs available to survivors of domestic violence

Yea

Passed

7–0

Apr 24, 2017

S 2722

Provides that a controlled substance analogue shall be deemed to be the controlled substance to which it is substantially similar or mimics

Yea

Passed

59–0

Apr 24, 2017

S 3518

Relates to controlled substances; defines synthetic cannabis

Yea

Passed

53–6

Apr 24, 2017

S 5393

Relates to extending current exemptions of income and resources for public assistance programs

Yea

Passed

7–0

Apr 24, 2017

S 816

Designates alpha-PVP, its salts, optical isomers and salts of optical isomers, as schedule I stimulant controlled substances

Yea

Passed

58–1

Apr 24, 2017